"The
Report Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Summary
Global
Markets Directs, Functional
(Non Ulcer) Dyspepsia
- Pipeline Review, H2 2016, provides an overview of the Functional
(Non Ulcer) Dyspepsia pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Functional (Non Ulcer) Dyspepsia, complete with
analysis by stage of development, drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type. The report
also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and
latest news and press releases. Additionally, the report provides an
overview of key players involved in therapeutic development for
Functional (Non Ulcer) Dyspepsia and features dormant and
discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/794409
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Functional (Non Ulcer) Dyspepsia
-
The report reviews pipeline therapeutics for Functional (Non Ulcer)
Dyspepsia by companies and universities/research institutes based on
information derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Functional (Non Ulcer)
Dyspepsia therapeutics and enlists all their major and minor projects
-
The report assesses Functional (Non Ulcer) Dyspepsia therapeutics
based on drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Functional (Non Ulcer) Dyspepsia
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Functional (Non Ulcer) Dyspepsia
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Functional (Non Ulcer) Dyspepsia pipeline depth and focus of
Indication therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
Of Content
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report
Coverage 5
Functional (Non Ulcer)
Dyspepsia Overview 6
Therapeutics Development 7
Pipeline Products for
Functional (Non Ulcer) Dyspepsia - Overview 7
Pipeline Products for
Functional (Non Ulcer) Dyspepsia - Comparative Analysis 8
Functional (Non Ulcer)
Dyspepsia - Therapeutics under Development by Companies 9
Functional (Non Ulcer)
Dyspepsia - Therapeutics under Investigation by
Universities/Institutes 10
Functional (Non Ulcer)
Dyspepsia - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Functional (Non Ulcer)
Dyspepsia - Products under Development by Companies 14
Functional (Non Ulcer)
Dyspepsia - Products under Investigation by Universities/Institutes
15
Functional (Non Ulcer)
Dyspepsia - Companies Involved in Therapeutics Development 16
Ironwood Pharmaceuticals, Inc.
16
RaQualia Pharma Inc. 17
Yuhan Corporation 18
Zensun (Shanghai) Sci &
Tech Co., Ltd. 19
Zeria Pharmaceutical Co., Ltd.
20
Functional (Non Ulcer)
Dyspepsia - Therapeutics Assessment 21
Assessment by Monotherapy
Products 21
Assessment by Target 22
Assessment by Mechanism of
Action 24
Assessment by Route of
Administration 26
Assessment by Molecule Type 27
Drug Profiles 29
5-BIOP - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
acotiamide hydrochloride - Drug
Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
LT-4005 - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
recanaclotide - Drug Profile 33
Product Description 33
Mechanism Of Action 33
R&D Progress 33
RQ-00000010 - Drug Profile 35
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment